For HR, CFO and WHS leaders
What is one late-stage diagnosis costing your business?
Model annual productivity loss, treatment exposure, workers compensation liability and workforce retention impact — across your real headcount.
Your workforce
Annual exposure
$1.07M
across approximately 18.2 expected skin cancer cases per year
Productivity loss
$173K
Treatment cost
$264K
Workers comp exposure
$311K
Retention / turnover
$324K
Methodology
How this number is calculated
An illustrative bottom-up model. Expected diagnoses are derived from your workforce mix, then four cost streams are applied per case. Assumptions are conservative and drawn from public sources — validate against your own claims and HR data before external use.
Expected diagnoses / yr
(outdoor × 13/1,000[2] × 1.8[4]) + (indoor × 13/1,000[2])
Base incidence of 13 per 1,000 employees, with a 1.8× UV multiplier on the outdoor share.
Productivity loss
diagnoses × 22 days[1] × (salary / 220[5])
22 working days lost per diagnosed employee, valued at their daily salary.
Workers comp exposure
diagnoses × 18%[3] × $95,000[3]
18% of cases trigger a claim, averaging $95K in employer-side exposure.
Retention / turnover
diagnoses × 25%[1] × (salary × 0.75[5])
25% of late-detected cases trigger an exit; replacement modelled at 75% of annual salary.
Total annual exposure
productivity + treatment + workers comp + retention
The four streams above, summed. Shown alongside expected case count.
Sources & references
- Deloitte Access Economics (2022) — The economic and social cost of skin cancer in Australia, commissioned by Melanoma Patients Australia. Source for productivity days lost and late-detection exit probability.
- AIHW — Cancer Data in Australia. Source for melanoma + significant NMSC incidence (13 per 1,000) and blended staged-treatment cost ($14,500/case).
- Safe Work Australia — Workers' Compensation Statistics. Source for the 18% claim-trigger rate and ~$95K average employer-side claim exposure for occupational cancers.
- Cancer Council Australia — UV radiation & outdoor work. Source for relative UV dose for outdoor vs indoor workforces (5–10× dose, modelled here as a conservative 1.8× incidence multiplier).
- AHRI — Turnover and Retention Research Report. Source for the 220 standard working-day base and the ~75% of annual salary replacement-cost benchmark for skilled roles.
Figures are modelled, illustrative and intended to frame board-level conversations. They are not a substitute for actuarial or accounting advice.
Modelling is illustrative, based on Deloitte Access Economics (2022), AIHW Cancer Data in Australia and Safe Work Australia exposure studies. Validate before external use.